Social anxiety disorder in primary care

General Hospital Psychiatry

Volumn 27, Issue 3, 2005, Pages 161-168

  Gross, Raz ^a,b,c   Olfson, Mark ^a,c   Gameroff, Marc J ^a,c   Shea, Steven ^a,b   Feder, Adriana ^a,c   Lantigua, Rafael ^a   Fuentes, Milton ^c   Weissman, Myrna M ^a,b,c  

^a Columbia University ^*  (United States)

^b New York State Psychiatric Institute ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Health services utilization; Primary care; Social anxiety disorder

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DISABILITY; FEMALE; FUNCTIONAL DISEASE; HEALTH CARE UTILIZATION; HEALTH PRACTITIONER; HEALTH SURVEY; HUMAN; MALE; MENTAL DISEASE; MENTAL HEALTH CARE; PREVALENCE; PRIMARY MEDICAL CARE; SOCIAL PHOBIA; SUBSTANCE ABUSE; TEACHING HOSPITAL;

ADOLESCENT; ADULT; AGED; ANXIETY; FEMALE; HEALTH SURVEYS; HOSPITALS, TEACHING; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; NEW YORK CITY; PREVALENCE; PRIMARY HEALTH CARE;

EID: 18844443728     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2005.01.006     Document Type: Article

References (63)

1. W.J. Magee, W.W. Eaton, H.U. Wittchen, K.A. McGonagle, and R.C. Kessler Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey Arch Gen Psychiatry 53 1996 159 168
2. D.J. Katzelnick, and J.H. Greist Social anxiety disorder: an unrecognized problem in primary care J Clin Psychiatry 62 Suppl 1 2001 11 15 [discussion 15-16]
3. K.A. Yonkers, I.R. Dyck, and M.B. Keller An eight-year longitudinal comparison of clinical course and characteristics of social phobia among men and women Psychiatr Serv 52 2001 637 643
4. F.R. Schneier, J. Johnson, C.D. Hornig, M.R. Liebowitz, and M.M. Weissman Social phobia. Comorbidity and morbidity in an epidemiologic sample Arch Gen Psychiatry 49 1992 282 288
5. R.C. Kessler, M.B. Stein, and P. Berglund Social phobia subtypes in the National Comorbidity Survey Am J Psychiatry 155 1998 613 619
6. N. Brunello, J.A. den Boer, and L.L. Judd Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment J Affect Disord 60 2000 61 74
7. C. Blanco, K. Nissenson, and M.R. Liebowitz Social anxiety disorder: recent findings in the areas of epidemiology, etiology, and treatment Curr Psychiatry Rep 3 2001 273 280
8. Bruce TJ, Saeed SA. Social anxiety disorder: a common, underrecognized mental disorder. Am Fam Physician 1999;60:2311-20, 2322.
9. M.R. Liebowitz Update on the diagnosis and treatment of social anxiety disorder J Clin Psychiatry 60 Suppl 18 1999 22 26
10. C.S. Fones, G.G. Manfro, and M.H. Pollack Social phobia: an update Harv Rev Psychiatry 5 1998 247 259
11. J.A. den Boer Social phobia: epidemiology, recognition, and treatment BMJ 315 1997 796 800
12. B.A. Raj, and D.V. Sheehan Social anxiety disorder Med Clin North Am 85 2001 711 733
13. M.R. Liebowitz, J.M. Gorman, A.J. Fyer, and D.F. Klein Social phobia. Review of a neglected anxiety disorder Arch Gen Psychiatry 42 1985 729 736
14. M.B. Stein, and D.A. Chavira Subtypes of social phobia and comorbidity with depression and other anxiety disorders J Affect Disord 50 Suppl 1 1998 S11 S16
15. L. Sareen, and M. Stein A review of the epidemiology and approaches to the treatment of social anxiety disorder Drugs 59 2000 497 509
16. M.B. Stein, J.R. McQuaid, C. Laffaye, and M.E. McCahill Social phobia in the primary care medical setting J Fam Pract 48 1999 514 519
17. J.C. Bisserbe, E. Weiller, P. Boyer, J.P. Lepine, and Y. Lecrubier Social phobia in primary care: level of recognition and drug use Int Clin Psychopharmacol 11 Suppl 3 1996 25 28
18. E. Weiller, J.C. Bisserbe, P. Boyer, J.P. Lepine, and Y. Lecrubier Social phobia in general health care: an unrecognised undertreated disabling disorder Br J Psychiatry 168 1996 169 174
19. L. Eisenberg Treating depression and anxiety in primary care. Closing the gap between knowledge and practice N Engl J Med 326 1992 1080 1084
20. D. Goldberg Epidemiology of mental disorders in primary care settings Epidemiol Rev 17 1995 182 190
21. M.B. Stein, and Y.M. Kean Disability and quality of life in social phobia: epidemiologic findings Am J Psychiatry 157 2000 1606 1613
22. A.J. Lang, and M.B. Stein Social phobia: prevalence and diagnostic threshold J Clin Psychiatry 62 Suppl 1 2001 5 10
23. M. Olfson, and H.A. Pincus Outpatient mental health care in nonhospital settings: distribution of patients across provider groups Am J Psychiatry 153 1996 1353 1356
24. R.V. Bijl, and A. Ravelli Psychiatric morbidity, service use, and need for care in the general population: results of The Netherlands Mental Health Survey and Incidence Study Am J Public Health 90 2000 602 607
25. H.U. Wittchen, and E. Beloch The impact of social phobia on quality of life Int Clin Psychopharmacol 11 Suppl 3 1996 15 23
26. R.P. Swinson, B.J. Cox, and C.B. Woszczyna Use of medical services and treatment for panic disorder with agoraphobia and for social phobia CMAJ, Can Med Assoc J 147 1992 878 883
27. P.L. Ritter, A.L. Stewart, H. Kaymaz, D.S. Sobel, D.A. Block, and K.R. Lorig Self-reports of health care utilization compared to provider records J Clin Epidemiol 54 2001 136 141
28. D.J. Katzelnick, K.A. Kobak, and T. DeLeire Impact of generalized social anxiety disorder in managed care Am J Psychiatry 158 2001 1999 2007
29. W. Zhang, J. Ross, and J.R. Davidson Social anxiety disorder in callers to the anxiety disorders association of America Depress Anxiety 20 2004 101 106
30. M. Olfson, M. Guardino, E. Struening, F.R. Schneier, F. Hellman, and D.F. Klein Barriers to the treatment of social anxiety Am J Psychiatry 157 2000 521 527
31. M. Olfson, S. Shea, and A. Feder Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice Arch Fam Med 9 2000 876 883
32. World Health Organization Composite International Diagnostic Interview (CIDI): version 2.1 1997 World Health Organization Geneva (Switzerland)
33. G. Andrews, and L. Peters The psychometric properties of the Composite International Diagnostic Interview Soc Psychiatry Psychiatr Epidemiol 33 1998 80 88
34. J. Ormel, M. VonKorff, T.B. Ustun, S. Pini, A. Korten, and T. Oldehinkel Common mental disorders and disability across cultures. Results from the WHO collaborative study on psychological problems in general health care JAMA 272 1994 1741 1748
35. L.N. Robins, J. Wing, and H.U. Wittchen The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures Arch Gen Psychiatry 45 1988 1069 1077
36. C.A. McHorney, J.E. Ware Jr., and A.E. Raczek The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs Med Care 31 1993 247 263
37. J.E. Ware Jr., and C.D. Sherbourne The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection Med Care 30 1992 473 483
38. M.M. Weissman, and S. Bothwell Assessment of social adjustment by patient self-report Arch Gen Psychiatry 33 1976 1111 1115
39. D.V. Sheehan, K. Harnett-Sheehan, and B.A. Raj The measurement of disability Int Clin Psychopharmacol 11 Suppl 3 1996 89 95
40. A.C. Leon, M. Olfson, L. Portera, L. Farber, and D.V. Sheehan Assessing psychiatric impairment in primary care with the Sheehan Disability Scale Int J Psychiatry Med 27 1997 93 105
41. R.C. Kessler, K.A. McGonagle, and S. Zhao Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey Arch Gen Psychiatry 51 1994 8 19
42. E. Ginzberg Access to health care for Hispanics JAMA 265 1991 238 241
43. J. Johnson, M.M. Weissman, and G.L. Klerman Service utilization and social morbidity associated with depressive symptoms in the community JAMA 267 1992 1478 1483
44. S.D. Pearson, D.J. Katzelnick, G.E. Simon, W.G. Manning, C.P. Helstad, and H.J. Henk Depression among high utilizers of medical care J Gen Intern Med 14 1999 461 468
45. R.B. Lydiard Social anxiety disorder: comorbidity and its implications J Clin Psychiatry 62 Suppl 1 2001 17 23 [discussion 24]
46. M.G. Kushner, K.J. Sher, and B.D. Beitman The relation between alcohol problems and the anxiety disorders Am J Psychiatry 147 1990 685 695
47. J.P. Lepine, and A. Pelissolo Social phobia and alcoholism: a complex relationship J Affect Disord 50 Suppl 1 1998 S23 S28
48. The WHO World Mental Health Survey Consortium Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys JAMA 291 2004 2581 2590
49. M.B. Stein, I.J. Heuser, J.L. Juncos, and T.W. Uhde Anxiety disorders in patients with Parkinson's disease Am J Psychiatry 147 1990 217 220
50. J.R. Davidson, D.L. Hughes, L.K. George, and D.G. Blazer The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study Psychol Med 23 1993 709 718
51. S.K. Fifer, S.D. Mathias, D.L. Patrick, P.D. Mazonson, D.P. Lubeck, and D.P. Buesching Untreated anxiety among adult primary care patients in a health maintenance organization Arch Gen Psychiatry 51 1994 740 750
52. W.H. Schonfeld, C.J. Verboncoeur, S.K. Fifer, R.C. Lipschutz, D.P. Lubeck, and D.P. Buesching The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder J Affect Disord 43 1997 105 119
53. J.R. Davidson Pharmacotherapy of social anxiety disorder J Clin Psychiatry 59 Suppl 17 1998 47 53
54. M.B. Stein, M.R. Liebowitz, R.B. Lydiard, C.D. Pitts, W. Bushnell, and I. Gergel Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial JAMA 280 1998 708 713
55. M.B. Stein, A.J. Fyer, J.R. Davidson, M.H. Pollack, and B. Wiita Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study Am J Psychiatry 156 1999 756 760
56. M.A. Van Ameringen, R.M. Lane, and J.R. Walker Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study Am J Psychiatry 158 2001 275 281
57. M.R. Liebowitz, F. Schneier, and R. Campeas Phenelzine vs atenolol in social phobia. A placebo-controlled comparison Arch Gen Psychiatry 49 1992 290 300
58. R.G. Heimberg Current status of psychotherapeutic interventions for social phobia J Clin Psychiatry 62 Suppl 1 2001 36 42
59. R.G. Heimberg Cognitive-behavioral therapy for social anxiety disorder: current status and future directions Biol Psychiatry 51 2002 101 108
60. S. Blomhoff, T.T. Haug, and K. Helistrom Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia Br J Psychiatry 179 2001 23 30
61. J.C. Ballenger, J.R. Davidson, and Y. Lecrubier Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety J Clin Psychiatry 59 Suppl 17 1998 54 60
62. K.M. Connor, K.A. Kobak, L.E. Churchill, D. Katzelnick, and J.R. Davidson Mini-SPIN: a brief screening assessment for generalized social anxiety disorder Depress Anxiety 14 2001 137 140
63. M.B. Stein, L.J. Torgrud, and J.R. Walker Social phobia symptoms, subtypes, and severity: findings from a community survey Arch Gen Psychiatry 57 2000 1046 1052